| RS1730934090 |
WFS1
|
Health Risk |
Pathogenic |
— |
| RS1730936563 |
WFS1
|
Health Risk |
Uncertain risk allele |
Wolfram syndrome 1, Wolfram syndrome 1 |
| RS1730936877 |
WFS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Monogenic hearing loss, Monogenic hearing loss |
| RS1730945388 |
CEP135
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1730963697 |
WFS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Wolfram-like syndrome, Wolfram syndrome 1 |
| RS1730966561 |
WFS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cataract 41, Wolfram syndrome 1 |
| RS1730968028 |
WFS1
|
Health Risk |
Likely risk allele |
Autosomal dominant nonsyndromic hearing loss 6, Wolfram syndrome 1 |
| RS1730968164 |
WFS1
|
Health Risk |
Uncertain significance/Uncertain risk allele |
Type 2 diabetes mellitus, Wolfram syndrome 1 |
| RS1730973578 |
SEC24D
|
Health Risk |
Likely pathogenic |
— |
| RS1731078730 |
PEX5
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 2B, Peroxisome biogenesis disorder 2B |
| RS1731099484 |
OPA1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1731156302 |
EVC
|
Health Risk |
Likely pathogenic |
Curry-Hall syndrome, Ellis-van Creveld syndrome |
| RS1731162235 |
FRAS1
|
Health Risk |
Likely pathogenic |
— |
| RS1731205978 |
ADD1
|
Health Risk |
Likely pathogenic |
Esophageal atresia/tracheoesophageal fistula, Esophageal atresia/tracheoesophageal fistula |
| RS1731221844 |
WDR19
|
Health Risk |
Pathogenic |
Nephronophthisis 13, Nephronophthisis 13 |
| RS1731366707 |
MANBA
|
Health Risk |
Pathogenic |
Beta-D-mannosidosis, Beta-D-mannosidosis |
| RS1731409120 |
TBX1
|
Health Risk |
Pathogenic/Likely pathogenic |
DiGeorge syndrome, TBX1-related disorder |
| RS1731436153 |
FRAS1
|
Health Risk |
Likely pathogenic |
Fraser syndrome 1, Fraser syndrome 1 |
| RS1731469688 |
PIGG
|
Health Risk |
Likely pathogenic |
— |
| RS17316607 |
FKTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A |
| RS1731781760 |
CTBP1
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS1731852340 |
RARS2
|
Health Risk |
Pathogenic |
— |
| RS1732036148 |
RNF168
|
Health Risk |
Pathogenic |
— |
| RS1732043783 |
RNF168
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1732086609 |
OPA1
|
Health Risk |
Pathogenic |
Optic atrophy, Optic atrophy |
| RS1732133553 |
STUB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Spinocerebellar ataxia 48, Autosomal recessive spinocerebellar ataxia 16 |
| RS1732173818 |
SLC39A8
|
Health Risk |
Likely pathogenic |
SLC39A8-CDG, SLC39A8-CDG |
| RS1732195544 |
SCARB2
|
Health Risk |
Pathogenic |
Progressive myoclonic epilepsy, Action myoclonus-renal failure syndrome |
| RS1732274672 |
FRAS1
|
Health Risk |
Likely pathogenic |
— |
| RS1732338984 |
SCARB2
|
Health Risk |
Likely pathogenic |
Progressive myoclonic epilepsy, Progressive myoclonic epilepsy |
| RS1732397227 |
CLCN3
|
Health Risk |
Likely pathogenic |
Neurodevelopmental delay, Neurodevelopmental disorder with hypotonia and brain abnormalities |
| RS1732439983 |
MANBA
|
Health Risk |
Pathogenic/Likely pathogenic |
Beta-D-mannosidosis, Beta-D-mannosidosis |
| RS1732611964 |
CLCN3
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1732670701 |
NEK1
|
Health Risk |
Pathogenic |
Short-rib thoracic dysplasia 6 with or without polydactyly, Short-rib thoracic dysplasia 6 with or without polydactyly |
| RS1732687174 |
GRID2
|
Health Risk |
Pathogenic |
Autosomal recessive spinocerebellar ataxia 18, Autosomal recessive spinocerebellar ataxia 18 |
| RS1732698125 |
SCARB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Progressive myoclonic epilepsy, Action myoclonus-renal failure syndrome |
| RS1732760873 |
AFG2A
|
Health Risk |
Pathogenic |
Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome, Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome |
| RS1732788163 |
OPA1
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1732803804 |
ANTXR2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyaline fibromatosis syndrome, Hyaline fibromatosis syndrome |
| RS1732838323 |
LRAT
|
Health Risk |
Pathogenic |
— |
| RS1732840025 |
LRAT
|
Health Risk |
Pathogenic |
Autosomal recessive retinitis pigmentosa, Leber congenital amaurosis 14 |
| RS1732848653 |
LRAT
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 14, Leber congenital amaurosis 14 |
| RS1732856311 |
FRAS1
|
Health Risk |
Pathogenic |
Fraser syndrome 1, Fraser syndrome 1 |
| RS1732862259 |
FRAS1
|
Health Risk |
Pathogenic |
— |
| RS1732862637 |
FRAS1
|
Health Risk |
Pathogenic |
Fraser syndrome 1, Fraser syndrome 1 |
| RS1732900321 |
CLCN3
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental delay |
| RS1732935012 |
LRAT
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 14, Leber congenital amaurosis 14 |
| RS1733002976 |
CYP2U1
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 56, Hereditary spastic paraplegia 56 |
| RS1733026743 |
CLCN3
|
Health Risk |
Pathogenic |
Autism, susceptiblity to |
| RS1733081846 |
OPA1
|
Health Risk |
Pathogenic |
Optic atrophy, Optic atrophy |
| RS1733108376 |
SCARB2
|
Health Risk |
Likely pathogenic |
Action myoclonus-renal failure syndrome, Action myoclonus-renal failure syndrome |
| RS1733155852 |
FRAS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Fraser syndrome 1, Fraser syndrome 1 |
| RS1733174455 |
PRMT9
|
Health Risk |
Pathogenic |
Neurodevelopmental abnormality, Neurodevelopmental abnormality |
| RS1733210295 |
PROM1
|
Health Risk |
Pathogenic |
— |
| RS1733212554 |
PROM1
|
Health Risk |
Likely pathogenic |
Cone-rod dystrophy 12, Cone-rod dystrophy 12 |
| RS1733238245 |
WDFY3
|
Health Risk |
Likely pathogenic |
Microcephaly 18, primary |
| RS1733349358 |
BMPR1B
|
Health Risk |
Likely pathogenic |
— |
| RS1733504639 |
WDR19
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Asphyxiating thoracic dystrophy 5 |
| RS1733648064 |
CYP2U1
|
Health Risk |
Pathogenic |
Intellectual disability, Lower limb spasticity |
| RS17337079 |
EGFR
|
Health Risk |
Conflicting classifications of pathogenicity |
EGFR-related lung cancer, Hereditary cancer-predisposing syndrome |
| RS1733868277 |
PHOX2B
|
Health Risk |
Pathogenic |
Neuroblastoma, susceptibility to |
| RS1733874227 |
PHOX2B
|
Health Risk |
Pathogenic |
— |
| RS1733876864 |
PHOX2B
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1733878065 |
PHOX2B
|
Health Risk |
Pathogenic |
Congenital central hypoventilation, PHOX2B-related disorder |
| RS1733881278 |
PHOX2B
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, PHOX2B-related disorder |
| RS1733890628 |
PHOX2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Haddad syndrome, Hereditary cancer-predisposing syndrome |
| RS1733894573 |
PHOX2B
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1733919437 |
FRAS1
|
Health Risk |
Likely pathogenic |
— |
| RS1733941453 |
PHOX2B
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital central hypoventilation, Hereditary cancer-predisposing syndrome |
| RS1733945703 |
PHOX2B
|
Health Risk |
Likely pathogenic |
Congenital central hypoventilation syndrome, with or without Hirschsprung disease |
| RS1733947320 |
PHOX2B
|
Health Risk |
Pathogenic |
Congenital central hypoventilation, Hereditary cancer-predisposing syndrome |
| RS1733978179 |
OPA1
|
Health Risk |
Pathogenic |
— |
| RS1733985177 |
PHOX2B;PHOX2B-AS1
|
Health Risk |
Pathogenic |
— |
| RS1734053435 |
PDE6B
|
Health Risk |
Pathogenic |
— |
| RS1734056711 |
PDE6B
|
Health Risk |
Pathogenic |
Autosomal recessive retinitis pigmentosa, Autosomal recessive retinitis pigmentosa |
| RS1734061080 |
NDUFS6
|
Health Risk |
Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 9 |
| RS1734061767 |
PDE6B
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa 40 |
| RS1734066308 |
PDE6B
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 40, Retinitis pigmentosa 40 |
| RS1734066547 |
PDE6B
|
Health Risk |
Pathogenic |
Cone-rod dystrophy, Retinal dystrophy |
| RS1734075026 |
PDE6B
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1734162973 |
OPA1
|
Health Risk |
Likely pathogenic |
Optic atrophy, Autosomal dominant optic atrophy classic form |
| RS1734176382 |
OPA1
|
Health Risk |
Pathogenic |
— |
| RS1734259370 |
FRAS1
|
Health Risk |
Pathogenic |
Fraser syndrome 1, Fraser syndrome 1 |
| RS1734300591 |
NDUFS6
|
Health Risk |
Pathogenic |
Mitochondrial complex I deficiency, nuclear type 9 |
| RS1734373037 |
PRDM5
|
Health Risk |
Likely pathogenic |
Brittle cornea syndrome 2, Brittle cornea syndrome 2 |
| RS1734381962 |
PRDM5
|
Health Risk |
Likely pathogenic |
Brittle cornea syndrome 2, Brittle cornea syndrome 2 |
| RS1734386587 |
GRIA2
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with language impairment and behavioral abnormalities, Neurodevelopmental disorder with language impairment and behavioral abnormalities |
| RS1734410152 |
SLC25A4
|
Health Risk |
Likely pathogenic |
— |
| RS1734410318 |
SLC25A4
|
Health Risk |
Pathogenic |
— |
| RS1734453026 |
OPA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Abortive cerebellar ataxia, Abortive cerebellar ataxia |
| RS1734559010 |
PROM1
|
Health Risk |
Pathogenic |
— |
| RS1734625225 |
SLC39A8
|
Health Risk |
Likely pathogenic |
SLC39A8-CDG, SLC39A8-CDG |
| RS1734697591 |
TRAPPC11
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type R18, Inborn genetic diseases |
| RS1734714805 |
TRAPPC11
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type R18, Autosomal recessive limb-girdle muscular dystrophy type R18 |
| RS1734720424 |
FAT4
|
Health Risk |
Pathogenic |
— |
| RS1734738637 |
HEXA
|
Health Risk |
Pathogenic |
Tay-Sachs disease, Tay-Sachs disease |
| RS1734829878 |
SDHA
|
Health Risk |
Pathogenic |
Mitochondrial complex II deficiency, nuclear type 1 |
| RS1734830402 |
SDHA
|
Health Risk |
Pathogenic |
Mitochondrial complex II deficiency, nuclear type 1 |
| RS1734832099 |
SDHA
|
Health Risk |
Pathogenic |
Pheochromocytoma/paraganglioma syndrome 5, Mitochondrial complex II deficiency |
| RS1734835445 |
BMPR1B
|
Health Risk |
Likely pathogenic |
Acromesomelic dysplasia 2C, Hunter-Thompson type |